NO20030375D0 - N-substituerte 1-amino-1,1-dialkylkarboksylsyrederivater - Google Patents
N-substituerte 1-amino-1,1-dialkylkarboksylsyrederivaterInfo
- Publication number
- NO20030375D0 NO20030375D0 NO20030375A NO20030375A NO20030375D0 NO 20030375 D0 NO20030375 D0 NO 20030375D0 NO 20030375 A NO20030375 A NO 20030375A NO 20030375 A NO20030375 A NO 20030375A NO 20030375 D0 NO20030375 D0 NO 20030375D0
- Authority
- NO
- Norway
- Prior art keywords
- amino
- substituted
- acid derivatives
- dialkylcarboxylic acid
- dialkylcarboxylic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10036121A DE10036121A1 (de) | 2000-07-25 | 2000-07-25 | N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate |
PCT/EP2001/007596 WO2002008177A2 (de) | 2000-07-25 | 2001-07-03 | N-substituierte-1-amino-1,1-dialkylcarbonsäurederivate |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20030375L NO20030375L (no) | 2003-01-24 |
NO20030375D0 true NO20030375D0 (no) | 2003-01-24 |
Family
ID=7650099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20030375A NO20030375D0 (no) | 2000-07-25 | 2003-01-24 | N-substituerte 1-amino-1,1-dialkylkarboksylsyrederivater |
Country Status (18)
Country | Link |
---|---|
US (1) | US20030162814A1 (zh) |
EP (1) | EP1303482A2 (zh) |
JP (1) | JP2004504375A (zh) |
KR (1) | KR20030022163A (zh) |
CN (1) | CN1443160A (zh) |
AR (1) | AR029980A1 (zh) |
AU (1) | AU2001293697A1 (zh) |
BR (1) | BR0112771A (zh) |
CA (1) | CA2418173A1 (zh) |
CZ (1) | CZ2003338A3 (zh) |
DE (1) | DE10036121A1 (zh) |
HU (1) | HUP0302948A2 (zh) |
MX (1) | MXPA03000664A (zh) |
NO (1) | NO20030375D0 (zh) |
PL (1) | PL358585A1 (zh) |
SK (1) | SK1512003A3 (zh) |
WO (1) | WO2002008177A2 (zh) |
ZA (1) | ZA200301471B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10110325A1 (de) * | 2001-03-03 | 2002-09-05 | Merck Patent Gmbh | Phenylderivate 2 |
US7030141B2 (en) | 2001-11-29 | 2006-04-18 | Christopher Franklin Bigge | Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
EP1476419B1 (en) * | 2002-02-08 | 2006-02-01 | Merck & Co., Inc. | N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
AR038377A1 (es) | 2002-02-08 | 2005-01-12 | Merck & Co Inc | Derivados de n-bifenil-aminocicloalcancarboxamida (con sustitucion con metilo) |
WO2004024679A1 (en) * | 2002-09-11 | 2004-03-25 | Warner-Lambert Company Llc | Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
BRPI0814627A2 (pt) | 2007-07-10 | 2015-01-27 | Sanofi Aventis | Derivados de malonamida com atividade antitrombótica |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU180240B (en) * | 1978-04-21 | 1983-02-28 | Gyogyszerkutato Intezet | Process for producing new,substituted 1,3-diaryl-2-iminoimidasolidines and 2-imino-hexahydro-pyrimidines |
US4310429A (en) * | 1978-06-19 | 1982-01-12 | The B. F. Goodrich Company | Stabilized polymers, novel stabilizers, and synthesis thereof |
CN1268116A (zh) * | 1997-08-27 | 2000-09-27 | 橘生药品工业株式会社 | 3-脒基苯胺衍生物,活化血凝固因子x抑制剂和制备这些物质的中间体 |
-
2000
- 2000-07-25 DE DE10036121A patent/DE10036121A1/de not_active Withdrawn
-
2001
- 2001-07-03 BR BR0112771-3A patent/BR0112771A/pt not_active Application Discontinuation
- 2001-07-03 US US10/333,633 patent/US20030162814A1/en not_active Abandoned
- 2001-07-03 EP EP01974078A patent/EP1303482A2/de not_active Withdrawn
- 2001-07-03 WO PCT/EP2001/007596 patent/WO2002008177A2/de not_active Application Discontinuation
- 2001-07-03 MX MXPA03000664A patent/MXPA03000664A/es unknown
- 2001-07-03 HU HU0302948A patent/HUP0302948A2/hu unknown
- 2001-07-03 KR KR1020027017764A patent/KR20030022163A/ko not_active Application Discontinuation
- 2001-07-03 CA CA002418173A patent/CA2418173A1/en not_active Abandoned
- 2001-07-03 CZ CZ2003338A patent/CZ2003338A3/cs unknown
- 2001-07-03 AU AU2001293697A patent/AU2001293697A1/en not_active Abandoned
- 2001-07-03 SK SK151-2003A patent/SK1512003A3/sk unknown
- 2001-07-03 PL PL01358585A patent/PL358585A1/xx unknown
- 2001-07-03 JP JP2002514086A patent/JP2004504375A/ja active Pending
- 2001-07-03 CN CN01813181A patent/CN1443160A/zh active Pending
- 2001-07-25 AR ARP010103542A patent/AR029980A1/es unknown
-
2003
- 2003-01-24 NO NO20030375A patent/NO20030375D0/no not_active Application Discontinuation
- 2003-02-24 ZA ZA200301471A patent/ZA200301471B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2004504375A (ja) | 2004-02-12 |
NO20030375L (no) | 2003-01-24 |
CA2418173A1 (en) | 2003-01-23 |
WO2002008177A8 (de) | 2002-04-18 |
MXPA03000664A (es) | 2003-06-06 |
AU2001293697A1 (en) | 2002-02-05 |
WO2002008177A2 (de) | 2002-01-31 |
BR0112771A (pt) | 2003-06-24 |
AR029980A1 (es) | 2003-07-23 |
DE10036121A1 (de) | 2002-02-07 |
HUP0302948A2 (hu) | 2003-12-29 |
PL358585A1 (en) | 2004-08-09 |
CZ2003338A3 (cs) | 2003-05-14 |
ZA200301471B (en) | 2004-06-29 |
US20030162814A1 (en) | 2003-08-28 |
EP1303482A2 (de) | 2003-04-23 |
SK1512003A3 (en) | 2003-07-01 |
KR20030022163A (ko) | 2003-03-15 |
WO2002008177A3 (de) | 2002-07-25 |
CN1443160A (zh) | 2003-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2016002I1 (el) | Ν-υποκατεστημενο καρβαμουλοξυαλκυλιο - παραγωγα αζολιου | |
NO20035634L (no) | Diamin-derivater | |
DK1292604T3 (da) | 2-Aminocarbonyl-9H-purinderivater | |
EE200300175A (et) | Tsüanopürrolidiini derivaadid | |
ATE298332T1 (de) | Decahydro-isochinolinderivate | |
DK1280809T3 (da) | Antitumorecteinascidinderivater | |
ATE309220T1 (de) | Substituierte 1,2,3,4-tetrahydrochinolin-2- carbonsäurederivate | |
DE50114491D1 (de) | Substituierte C-Cyclohexylmethylamin-Derivative | |
DK1353910T3 (da) | Lactamforbindelse | |
DK1153014T3 (da) | Beta-alaninderivater | |
NO20025542L (no) | Kinolonkarboksylsyrederivater | |
DK1322593T3 (da) | O-substituerede-6-methyl-tramadol-derivater | |
ATE282021T1 (de) | Substituierte aminomethyl-phenyl- cyclohexanderivate | |
NO20030375D0 (no) | N-substituerte 1-amino-1,1-dialkylkarboksylsyrederivater | |
ATE280752T1 (de) | Aminomethyl-phenyl-cyclohexanonderivate | |
DE60141206D1 (de) | Anilin-derivate | |
DE50003014D1 (de) | N-substituierte perhydrodiazine | |
DE50112454D1 (de) | Substituierte 5-amino-1-penten-3-ol-derivate | |
NO20021310D0 (no) | Aminderivater | |
ATE374776T1 (de) | Pyrrolotriazolopyrimidinonderivate | |
NO20024393D0 (no) | 2-fenylpyran-4-on-derivater | |
FI20000395A (fi) | N-(amidinobentsoyyli- tai amidinopyridyylikarbonyyli)-alfa-aminohappojohdannaisia | |
DK1305307T3 (da) | Indolderivater | |
DK1246793T3 (da) | Substituerede aminomethyl-phenyl-cyclohexanderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |